{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:27:56Z","timestamp":1789165676772,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82072898"],"award-info":[{"award-number":["82072898"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81773209"],"award-info":[{"award-number":["81773209"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81772932"],"award-info":[{"award-number":["81772932"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s10549-024-07409-4","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T07:02:07Z","timestamp":1718866927000},"page":"155-164","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Characteristics of Chinese breast cancer patients with double heterozygosity for BRCA1 and BRCA2 germline pathogenic variants"],"prefix":"10.1007","volume":"208","author":[{"given":"Song","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,20]]},"reference":[{"key":"7409_CR1","doi-asserted-by":"publisher","first-page":"6113","DOI":"10.1158\/1078-0432.CCR-16-3227","volume":"23","author":"J Sun","year":"2017","unstructured":"Sun J, Meng H, Yao L, Lv M, Bai J, Zhang J et al (2017) Germline mutations in cancer susceptibility genes in a large series of unselected breast cancer patients. Clin Cancer Res 23:6113\u20136119. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-3227","journal-title":"Clin Cancer Res"},{"key":"7409_CR2","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1002\/ijc.32184","volume":"145","author":"M Deng","year":"2019","unstructured":"Deng M, Chen HH, Zhu X, Luo M, Zhang K, Xu CJ et al (2019) Prevalence and clinical outcomes of germline mutations in and genes in 2769 unselected breast cancer patients in China. Int J Cancer 145:1517\u20131528. https:\/\/doi.org\/10.1002\/ijc.32184","journal-title":"Int J Cancer"},{"key":"7409_CR3","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1002\/ijc.32918","volume":"146","author":"LM Su","year":"2020","unstructured":"Su LM, Xu Y, Ouyang T, Li JF, Wang TF, Fan ZQ et al (2020) Contralateral breast cancer risk in and mutation carriers in a large cohort of unselected Chinese breast cancer patients. Int J Cancer 146:3335\u20133342. https:\/\/doi.org\/10.1002\/ijc.32918","journal-title":"Int J Cancer"},{"key":"7409_CR4","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ et al (2017) Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317:2402\u20132416. https:\/\/doi.org\/10.1001\/jama.2017.7112","journal-title":"JAMA"},{"key":"7409_CR5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10549-016-3766-3","volume":"156","author":"L Yao","year":"2016","unstructured":"Yao L, Sun J, Zhang J, He Y, Ouyang T, Li J et al (2016) Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations. Breast Cancer Res Treat 156:441\u2013445. https:\/\/doi.org\/10.1007\/s10549-016-3766-3","journal-title":"Breast Cancer Res Treat"},{"key":"7409_CR6","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1002\/ijc.32918","volume":"146","author":"L Su","year":"2020","unstructured":"Su L, Xu Y, Ouyang T, Li J, Wang T, Fan Z et al (2020) Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers in a large cohort of unselected Chinese breast cancer patients. Int J Cancer 146:3335\u20133342. https:\/\/doi.org\/10.1002\/ijc.32918","journal-title":"Int J Cancer"},{"key":"7409_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41431-021-01013-6","volume":"30","author":"A Mcguigan","year":"2022","unstructured":"Mcguigan A, Whitworth J, Andreou A, Hearn T, Tischkowitz M et al (2022) Multilocus inherited neoplasia allele syndrome (MINAS): an update. Eur J Hum Genet 30:265\u2013270. https:\/\/doi.org\/10.1038\/s41431-021-01013-6","journal-title":"Eur J Hum Genet"},{"key":"7409_CR8","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/annonc\/mdq460","volume":"22","author":"O Lavie","year":"2011","unstructured":"Lavie O, Narod S, Lejbkowicz F, Dishon S, Goldberg Y, Gemer O et al (2011) Double heterozygosity in the BRCA1 and BRCA2 genes in the Jewish population. Ann Oncol 22:964\u2013966. https:\/\/doi.org\/10.1093\/annonc\/mdq460","journal-title":"Ann Oncol"},{"key":"7409_CR9","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s10549-012-2050-4","volume":"134","author":"S Heidemann","year":"2012","unstructured":"Heidemann S, Fischer C, Engel C, Fischer B, Harder L, Schlegelberger B et al (2012) Double heterozygosity for mutations in BRCA1 and BRCA2 in German breast cancer patients: implications on test strategies and clinical management. Breast Cancer Res Treat 134:1229\u20131239. https:\/\/doi.org\/10.1007\/s10549-012-2050-4","journal-title":"Breast Cancer Res Treat"},{"key":"7409_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10549-011-1718-5","volume":"131","author":"JM Noh","year":"2012","unstructured":"Noh JM, Choi DH, Nam SJ, Lee JE, Kim JW, Kim SW et al (2012) Characteristics of double heterozygosity for BRCA1 and BRCA2 germline mutations in Korean breast cancer patients. Breast Cancer Res Treat 131:217\u2013222. https:\/\/doi.org\/10.1007\/s10549-011-1718-5","journal-title":"Breast Cancer Res Treat"},{"key":"7409_CR11","doi-asserted-by":"publisher","first-page":"827","DOI":"10.4143\/crt.2021.791","volume":"54","author":"YJ Bang","year":"2022","unstructured":"Bang YJ, Kwon WK, Nam SJ, Kim SW, Chae BJ, Lee SK et al (2022) Clinicopathological characterization of double heterozygosity for BRCA1 and BRCA2 variants in Korean breast cancer patients. Cancer Res Treat 54:827\u2013833. https:\/\/doi.org\/10.4143\/crt.2021.791","journal-title":"Cancer Res Treat"},{"key":"7409_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2004.027243","volume":"42","author":"B Leegte","year":"2005","unstructured":"Leegte B, van der Hout AH, Deffenbaugh AM, Bakker MK, Mulder IM, ten Berge A et al (2005) Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations. J Med Genet 42:e20. https:\/\/doi.org\/10.1136\/jmg.2004.027243","journal-title":"J Med Genet"},{"key":"7409_CR13","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13058-016-0768-3","volume":"18","author":"TR Rebbeck","year":"2016","unstructured":"Rebbeck TR, Friebel TM, Mitra N, Wan F, Chen S, Andrulis IL et al (2016) Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women. Breast Cancer Res 18:112. https:\/\/doi.org\/10.1186\/s13058-016-0768-3","journal-title":"Breast Cancer Res"},{"key":"7409_CR14","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1200\/JCO.2004.04.179","volume":"22","author":"DH Choi","year":"2004","unstructured":"Choi DH, Lee MH, Bale AE, Carter D, Haffty BG (2004) Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients. J Clin Oncol 22:1638\u20131645. https:\/\/doi.org\/10.1200\/JCO.2004.04.179","journal-title":"J Clin Oncol"},{"key":"7409_CR15","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1159\/000520148","volume":"14","author":"M Kitahara","year":"2021","unstructured":"Kitahara M, Hozumi Y, Machinaga M, Hayashi Y (2021) A case of triple-negative breast cancer with germline pathogenic variants in both BRCA1 and BRCA2. Case Rep Oncol 14:1645\u20131651. https:\/\/doi.org\/10.1159\/000520148","journal-title":"Case Rep Oncol"},{"key":"7409_CR16","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s12282-012-0432-4","volume":"22","author":"T Nomizu","year":"2015","unstructured":"Nomizu T, Matsuzaki M, Katagata N, Kobayashi Y, Sakuma T, Monma T et al (2015) A case of familial breast cancer with double heterozygosity for BRCA1 and BRCA2 genes. Breast Cancer 22:557\u2013561. https:\/\/doi.org\/10.1007\/s12282-012-0432-4","journal-title":"Breast Cancer"},{"key":"7409_CR17","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s10549-016-3902-0","volume":"158","author":"J Zhang","year":"2016","unstructured":"Zhang J, Sun J, Chen J, Yao L, Ouyang T, Li J et al (2016) Comprehensive analysis of BRCA1 and BRCA2 germline mutations in a large cohort of 5931 Chinese women with breast cancer. Breast Cancer Res Treat 158:455\u2013462. https:\/\/doi.org\/10.1007\/s10549-016-3902-0","journal-title":"Breast Cancer Res Treat"},{"key":"7409_CR18","doi-asserted-by":"publisher","unstructured":"Su L, Zhang J, Meng H, Ouyang T, Li J, Wang T et al (2018) Prevalence of BRCA1\/2 large genomic rearrangements in Chinese women with sporadic triple-negative or familial breast cancer. Clin Genet 94:165-169. https:\/\/doi.org\/10.1111\/cge.13256","DOI":"10.1111\/cge.13256"},{"key":"7409_CR19","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/annonc\/mdu559","volume":"26","author":"C Wang","year":"2015","unstructured":"Wang C, Zhang J, Wang Y, Ouyang T, Li J, Wang T et al (2015) Prevalence of BRCA1 mutations and responses to neoadjuvant chemotherapy among BRCA1 carriers and non-carriers with triple-negative breast cancer. Ann Oncol 26:523\u2013528. https:\/\/doi.org\/10.1093\/annonc\/mdu559","journal-title":"Ann Oncol"},{"key":"7409_CR20","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1002\/ijc.32877","volume":"146","author":"H Meng","year":"2020","unstructured":"Meng H, Yao L, Yuan H, Xu Y, Ouyang T, Li J et al (2020) BRCA1 c.5470_5477del, a founder mutation in Chinese Han breast cancer patients. Int J Cancer 146:3044\u20133052. https:\/\/doi.org\/10.1002\/ijc.32877","journal-title":"Int J Cancer"},{"key":"7409_CR21","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1200\/JCO.2002.20.6.1480","volume":"20","author":"TS Frank","year":"2002","unstructured":"Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B et al (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20:1480\u20131490. https:\/\/doi.org\/10.1200\/JCO.2002.20.6.1480","journal-title":"J Clin Oncol"},{"key":"7409_CR22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s10549-010-0853-8","volume":"124","author":"M Zuradelli","year":"2010","unstructured":"Zuradelli M, Peissel B, Manoukian S, Zaffaroni D, Barile M, Pensotti V et al (2010) Four new cases of double heterozygosity for BRCA1 and BRCA2 gene mutations: clinical, pathological, and family characteristics. Breast Cancer Res Treat 124:251\u2013258. https:\/\/doi.org\/10.1007\/s10549-010-0853-8","journal-title":"Breast Cancer Res Treat"},{"key":"7409_CR23","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1001\/jamaoncol.2022.0476","volume":"8","author":"Y Momozawa","year":"2022","unstructured":"Momozawa Y, Sasai R, Usui Y, Shiraishi K, Iwasaki Y, Taniyama Y et al (2022) Expansion of cancer risk profile for BRCA1 and BRCA2 pathogenic variants. JAMA Oncol 8:871\u2013878. https:\/\/doi.org\/10.1001\/jamaoncol.2022.0476","journal-title":"JAMA Oncol"},{"key":"7409_CR24","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1001\/jama.2018.6228","volume":"319","author":"C Hu","year":"2018","unstructured":"Hu C, Hart SN, Polley EC, Gnanaolivu R, Shimelis H, Lee KY et al (2018) Association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer. JAMA 319:2401\u20132409. https:\/\/doi.org\/10.1001\/jama.2018.6228","journal-title":"JAMA"},{"key":"7409_CR25","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1001\/jamaoncol.2019.2203","volume":"5","author":"ZM Wang","year":"2019","unstructured":"Wang ZM, Wilson CL, Armstrong GT, Hudson MM, Zhang JH, Nichols KE et al (2019) Association of germline BRCA2 mutations With the risk of pediatric or adolescent non-hodgkin lymphoma. JAMA Oncol 5:1362\u20131364. https:\/\/doi.org\/10.1001\/jamaoncol.2019.2203","journal-title":"JAMA Oncol"},{"key":"7409_CR26","doi-asserted-by":"publisher","first-page":"3972","DOI":"10.1111\/cas.15522","volume":"113","author":"Y Usui","year":"2022","unstructured":"Usui Y, Iwasaki Y, Matsuo K, Endo M, Kamatani Y, Hirata M et al (2022) Association between germline pathogenic variants in cancer-predisposing genes and lymphoma risk. Cancer Sci 113:3972\u20133979. https:\/\/doi.org\/10.1111\/cas.15522","journal-title":"Cancer Sci"},{"key":"7409_CR27","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2018.01.009","volume":"68","author":"CP Wardell","year":"2018","unstructured":"Wardell CP, Fujita M, Yamada T, Simbolo M, Fassan M, Karlic R et al (2018) Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations. J Hepatol 68:959\u2013969. https:\/\/doi.org\/10.1016\/j.jhep.2018.01.009","journal-title":"J Hepatol"},{"key":"7409_CR28","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1002\/cncr.32740","volume":"126","author":"H Maynard","year":"2020","unstructured":"Maynard H, Stadler ZK, Berger MF, Solit DB, Ly M, Lowery MA et al (2020) Germline alterations in patients with biliary tract cancers: a spectrum of significant and previously underappreciated findings. Cancer 126:1995\u20132002. https:\/\/doi.org\/10.1002\/cncr.32740","journal-title":"Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-024-07409-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-024-07409-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-024-07409-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T11:17:29Z","timestamp":1728040649000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-024-07409-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,20]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["7409"],"URL":"https:\/\/doi.org\/10.1007\/s10549-024-07409-4","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,20]]},"assertion":[{"value":"8 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Ethical approval for this work was obtained from Ethics Committee of Peking University Cancer Hospital (No. 2011KT12).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}